Exome Sequencing and the Management of Neurometabolic Disorders.
暂无分享,去创建一个
Andrea Superti-Furga | Rupasri Mandal | Wyeth W Wasserman | David Wishart | Ron A Wevers | Suzanne Lewis | Jan M Friedman | Casper Shyr | Maja Tarailo-Graovac | Jiqiang Ling | Patrice Eydoux | Tammie Dewan | D. Wishart | M. Baumgartner | C. Ross | W. Wasserman | P. Ruben | D. Zafeiriou | M. Tarailo-Graovac | L. Kluijtmans | R. Wevers | C. V. van Karnebeek | M. Demos | A. Lehman | Jessica J. Y. Lee | C. Shyr | R. Mandal | J. Rozmus | G. Horvath | M. Connolly | Jessica J. Y. Lee | R. Salvarinova | S. Santra | P. Eydoux | H. Vallance | Linhua Zhang | Amit P. Bhavsar | G. Sinclair | S. Stockler-Ipsiroglu | A. Mattman | X. Ye | B. Drögemöller | Mena Abdelsayed | M. Alfadhel | L. Armstrong | P. Burda | J. Cameron | T. Dewan | Janis Dionne | A. Evans | J. Friedman | I. Garber | S. Lewis | Jiqiang Ling | M. McKinnon | A. Michoulas | D. Metzger | O. Ogunbayo | Bojana Rakić | B. Sayson | K. R. Schultz | K. Selby | Paul Shekel | S. Sirrs | C. Skrypnyk | A. Superti-Furga | S. Turvey | M. V. Van Allen | Jiang Wu | John Wu | Majid Alfadhel | Colin J Ross | Gabriella A Horvath | Ramona Salvarinova | Xin C Ye | Lin-Hua Zhang | Amit P Bhavsar | Jessica J Y Lee | Britt I Drögemöller | Mena Abdelsayed | Linlea Armstrong | Matthias R Baumgartner | Patricie Burda | Mary B Connolly | Jessie Cameron | Michelle Demos | Janis Dionne | A Mark Evans | Ian Garber | Andre Mattman | Margaret McKinnon | Aspasia Michoulas | Daniel Metzger | Oluseye A Ogunbayo | Bojana Rakic | Jacob Rozmus | Peter Ruben | Bryan Sayson | Saikat Santra | Kirk R Schultz | Kathryn Selby | Paul Shekel | Sandra Sirrs | Cristina Skrypnyk | Stuart E Turvey | Margot I Van Allen | Jiang Wu | John Wu | Dimitrios Zafeiriou | Leo Kluijtmans | Anna M Lehman | Hilary Vallance | Sylvia Stockler-Ipsiroglu | Graham Sinclair | Clara D van Karnebeek | J. Dionne | John K Wu | C. Karnebeek | M. V. Allen | Lin Hua Zhang
[1] Alejandro Sifrim,et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.
[2] E. Bertini,et al. Altered PLP1 splicing causes hypomyelination of early myelinating structures , 2015, Annals of clinical and translational neurology.
[3] K. Uchida,et al. Induction of Phosphoenolpyruvate Carboxykinase (PEPCK) during Acute Acidosis and Its Role in Acid Secretion by V-ATPase-Expressing Ionocytes , 2015, International journal of biological sciences.
[4] Michael R. Kuehn,et al. Mutation of SENP1/SuPr-2 Reveals an Essential Role for Desumoylation in Mouse Development , 2005, Molecular and Cellular Biology.
[5] Jana Marie Schwarz,et al. MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.
[6] C. V. van Karnebeek,et al. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome. , 2015, Molecular genetics and metabolism.
[7] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[8] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[9] K. Friend,et al. X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes , 2015, Molecular Psychiatry.
[10] Yongwook Choi,et al. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..
[11] A. Baruchel,et al. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia , 2010, Journal of Medical Genetics.
[12] K. F. Fajardo,et al. Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity. , 2014, Molecular genetics and metabolism.
[13] E. Shoubridge,et al. RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement , 2015, European Journal of Human Genetics.
[14] J. Polder,et al. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study , 1998, BMJ.
[15] L. Vissers,et al. Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. , 2012, American journal of human genetics.
[16] Mitsunori Fukuda,et al. Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes , 2004, Nature Cell Biology.
[17] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[18] Sylvia Stockler,et al. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. , 2012, Molecular genetics and metabolism.
[19] J. B. Oliveira,et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. , 2011, Blood.
[20] M. Zhu,et al. Cyclic Adenosine Diphosphate Ribose Activates Ryanodine Receptors, whereas NAADP Activates Two-pore Domain Channels* , 2011, The Journal of Biological Chemistry.
[21] Mohamed Abouelhoda,et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. , 2015, Cell reports.
[22] H. Varmus,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.
[23] I. Adzhubei,et al. Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.
[24] C. Ward,et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. , 2008, The Journal of clinical investigation.
[25] J. Mackrill,et al. Ryanodine receptor calcium channels and their partners as drug targets. , 2010, Biochemical pharmacology.
[26] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[27] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[28] Epilepsy Phenome,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[29] P. Pavlidis,et al. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target? , 2016, Molecular genetics and metabolism.
[30] C. Krarup,et al. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy , 2015, Brain : a journal of neurology.
[31] Lisa G Shaffer,et al. Genetic basis of intellectual disability. , 2013, Annual review of medicine.
[32] T. Coşkun,et al. An update on serine deficiency disorders , 2013, Journal of Inherited Metabolic Disease.
[33] H. Bellen,et al. Introduction to Notch signaling. , 2014, Methods in molecular biology.
[34] D. Lev,et al. Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome , 2013, Neurology.
[35] Lora J. H. Bean,et al. Free the Data: One Laboratory's Approach to Knowledge‐Based Genomic Variant Classification and Preparation for EMR Integration of Genomic Data , 2013, Human mutation.
[36] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[37] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[38] C. Ackerley,et al. Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking , 2014, Orphanet Journal of Rare Diseases.
[39] Mustafa Tekin,et al. GJB2 mutations and degree of hearing loss: a multicenter study. , 2005, American journal of human genetics.
[40] W. Sly,et al. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. , 2014, American journal of human genetics.
[41] Arne Schousboe,et al. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. , 2006, Biochemical pharmacology.
[42] Dian Donnai,et al. NANS-mediated synthesis of sialic acid is required for brain and skeletal development , 2016, Nature Genetics.
[43] J. Neoptolemos,et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis , 2002, Gut.
[44] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[45] J. Rilstone,et al. Brain dopamine-serotonin vesicular transport disease and its treatment. , 2013, The New England journal of medicine.
[46] E. Bertini,et al. MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert Syndrome related disorder with liver involvement , 2009, Human mutation.
[47] P. Pavlidis,et al. Expansion of the QARS deficiency phenotype with report of a family with isolated supratentorial brain abnormalities , 2015, neurogenetics.
[48] M. Mattei,et al. Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization. , 1994, Genomics.
[49] S. Calvieri,et al. Griscelli Syndrome Type 2: Long-Term Follow-Up after Unrelated Donor Bone Marrow Transplantation , 2009, Dermatology.
[50] F Bertocchini,et al. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning , 1999, The EMBO journal.
[51] R. Berger,et al. Quantification of free and total sialic acid excretion by LC-MS/MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[52] C. Walsh,et al. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. , 2014, American journal of human genetics.
[53] Peter Lipp,et al. RyR1 and RyR3 isoforms provide distinct intracellular Ca2+ signals in HEK 293 cells. , 2002, Journal of cell science.
[54] Robert W. Taylor,et al. Accurate mitochondrial DNA sequencing using off-target reads provides a single test to identify pathogenic point mutations , 2014, Genetics in Medicine.
[55] A. Fischer,et al. A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. , 2008, Blood.
[56] Hans van Bokhoven,et al. Genetic and epigenetic networks in intellectual disabilities. , 2011, Annual review of genetics.
[57] K. Foley. Model network: Canadian program aims to generate models for rare disease , 2015, Nature Medicine.
[58] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[59] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[60] K. Mikoshiba,et al. The Slp Homology Domain of Synaptotagmin-like Proteins 1–4 and Slac2 Functions as a Novel Rab27A Binding Domain* , 2002, The Journal of Biological Chemistry.
[61] A. Fischer,et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome , 2000, Nature Genetics.
[62] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[63] N. Nishiyama,et al. Generation and Characterization of Mutant Mice Lacking Ryanodine Receptor Type 3* , 1996, The Journal of Biological Chemistry.
[64] S. Saxena,et al. Intellectual developmental disorders: towards a new name, definition and framework for “mental retardation/intellectual disability” in ICD‐11 , 2011, World psychiatry : official journal of the World Psychiatric Association.
[65] P. Hieter,et al. Understanding Rare Disease Pathogenesis: A Grand Challenge for Model Organisms , 2014, Genetics.
[66] Joseph K. Pickrell,et al. A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.
[67] A. Di Carlo,et al. COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. , 1996, American journal of medical genetics.
[68] Wyeth W Wasserman,et al. FLAGS, frequently mutated genes in public exomes , 2014, BMC Medical Genomics.
[69] S. Langlois,et al. V37I connexin 26 allele in patients with sensorineural hearing loss: Evidence of its pathogenicity , 2006, American journal of medical genetics. Part A.
[70] A. Terzic,et al. BIOTECHNOLOGICALLY RELEVANT ENZYMES AND PROTEINS Human acetyl-CoA carboxylase 2 expressed in silkworm Bombyx mori exhibits posttranslational biotinylation and phosphorylation , 2014 .
[71] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[72] D. Wishart,et al. Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms , 2015, Orphanet Journal of Rare Diseases.
[73] S. Bekheit,et al. Ryanodine Calcium Channel: A Novel Channelopathy for Seizures , 2011, The neurologist.
[74] Steven J. M. Jones,et al. FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. , 2014, American journal of human genetics.
[75] C. Ross,et al. The genotypic and phenotypic spectrum of PIGA deficiency , 2015, Orphanet Journal of Rare Diseases.
[76] C. Ji,et al. A novel splice variant of human gene NPL, mainly expressed in human liver, kidney and peripheral blood leukocyte , 2005, DNA sequence : the journal of DNA sequencing and mapping.
[77] Yujun Han,et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios , 2015, Genetics in Medicine.
[78] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[79] C. Ross,et al. AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset , 2014, neurogenetics.
[80] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[81] R. Płoski,et al. M34T and V37I mutations in GJB2 associated hearing impairment: Evidence for pathogenicity and reduced penetrance , 2007, American journal of medical genetics. Part A.
[82] C. V. van Karnebeek,et al. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. , 2014, Molecular genetics and metabolism.
[83] S. Falkmer,et al. Persistent neonatal hypoglycaemia. A clinical and histopathological study of three cases treated with diazoxide and subtotal pancreatectomy. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.